title: Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment.
abstract: Type 2 diabetes is characterized by both peripheral insulin resistance and reduced insulin secretion by beta-cells. The reasons for beta-cell dysfunction in this disease are incompletely understood but may include the accumulation of toxic lipids within this cell type. We examined the role of Abca1, a cellular cholesterol transporter, in cholesterol homeostasis and insulin secretion in beta-cells. Mice with specific inactivation of Abca1 in beta-cells had markedly impaired glucose tolerance and defective insulin secretion but normal insulin sensitivity. Islets isolated from these mice showed altered cholesterol homeostasis and impaired insulin secretion in vitro. We found that rosiglitazone, an activator of the peroxisome proliferator-activated receptor-gamma, which upregulates Abca1 in beta-cells, requires beta-cell Abca1 for its beneficial effects on glucose tolerance. These experiments establish a new role for Abca1 in beta-cell cholesterol homeostasis and insulin secretion, and suggest that cholesterol accumulation may contribute to beta-cell dysfunction in type 2 diabetes.
authors.affiliation: Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, University of British Columbia, 950 West 28th Avenue, Vancouver, British Columbia V5Z 4H4, Canada.
authors.forename: Liam R
authors.initials: LR
authors.lastname: Brunham
authors.forename: Janine K
authors.initials: JK
authors.lastname: Kruit
authors.forename: Terry D
authors.initials: TD
authors.lastname: Pape
authors.forename: Jenelle M
authors.initials: JM
authors.lastname: Timmins
authors.forename: Anne Q
authors.initials: AQ
authors.lastname: Reuwer
authors.forename: Zainisha
authors.initials: Z
authors.lastname: Vasanji
authors.forename: Brad J
authors.initials: BJ
authors.lastname: Marsh
authors.forename: Brian
authors.initials: B
authors.lastname: Rodrigues
authors.forename: James D
authors.initials: JD
authors.lastname: Johnson
authors.forename: John S
authors.initials: JS
authors.lastname: Parks
authors.forename: C Bruce
authors.initials: CB
authors.lastname: Verchere
authors.forename: Michael R
authors.initials: MR
authors.lastname: Hayden
mesh_terms: D064286:ATP Binding Cassette Transporter 1; D018528:ATP-Binding Cassette Transporters / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D000818:Animals; D002784:Cholesterol / Q000378:metabolism; D005947:Glucose / Q000378:metabolism*; D006706:Homeostasis / Q000187:drug effects / Q000502:physiology*; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D050417:Insulin-Secreting Cells / Q000187:drug effects* / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D045162:Thiazolidinediones / Q000494:pharmacology*
chemical_list: D064286:ATP Binding Cassette Transporter 1; D018528:ATP-Binding Cassette Transporters; D007004:Hypoglycemic Agents; D007328:Insulin; D045162:Thiazolidinediones; D002784:Cholesterol; C089946:2,4-thiazolidinedione; D005947:Glucose